Atomwise Reviews

eLabNext is revolutionizing laboratories across the globe with innovative digital solutions designed for the future. Our Digital Lab Platform (DLP) integrates essential tools such as Electronic Lab Notebooks (ELN) and Laboratory Information Management Systems (LIMS), alongside cutting-edge technologies like artificial intelligence and machine learning. Engineered for effortless integration with your laboratory's existing hardware and software, this platform significantly boosts flexibility, security, and overall efficiency. By streamlining and optimizing your research and development processes within a secure and compliant framework, we enable researchers to focus more on driving innovation. Our dedicated team of experts is here to assist you throughout every phase of your digital lab transformation journey, ensuring a smooth transition. Additionally, eLabNext operates under the umbrella of Bio-ITech BV, which is affiliated with the Eppendorf Group.

StackAI is an enterprise AI automation platform built to help organizations create end-to-end internal tools and processes with AI agents. Unlike point solutions or one-off chatbots, StackAI provides a single platform where enterprises can design, deploy, and govern AI workflows in a secure, compliant, and fully controlled environment. Using its visual workflow builder, teams can map entire processes — from data intake and enrichment to decision-making, reporting, and audit trails. Enterprise knowledge bases such as SharePoint, Confluence, Notion, Google Drive, and internal databases can be connected directly, with features for version control, citations, and permissioning to keep information reliable and protected. AI agents can be deployed in multiple ways: as a chat assistant embedded in daily workflows, an advanced form for structured document-heavy tasks, or an API endpoint connected into existing tools. StackAI integrates natively with Slack, Teams, Salesforce, HubSpot, ServiceNow, Airtable, and more. Security and compliance are embedded at every layer. The platform supports SSO (Okta, Azure AD, Google), role-based access control, audit logs, data residency, and PII masking. Enterprises can monitor usage, apply cost controls, and test workflows with guardrails and evaluations before production. StackAI also offers flexible model routing, enabling teams to choose between OpenAI, Anthropic, Google, or local LLMs, with advanced settings to fine-tune parameters and ensure consistent, accurate outputs. A growing template library speeds deployment with pre-built solutions for Contract Analysis, Support Desk Automation, RFP Response, Investment Memo Generation, and InfoSec Questionnaires. By replacing fragmented processes with secure, AI-driven workflows, StackAI helps enterprises cut manual work, accelerate decision-making, and empower non-technical teams to build automation that scales across the organization.

BIOiSIMTM is a revolutionary virtual drug development engine that offers significant advantages to the pharmaceutical industry by adeptly identifying drug compounds with strong potential for addressing specific diseases. Our range of translational solutions is designed to align with the unique requirements of your pre-clinical and clinical projects. At the heart of these offerings lies our trustworthy and validated BIOiSIMTM platform, which supports research on small molecules, large molecules, and viruses. Utilizing advanced models, this platform draws on data from thousands of compounds across seven different species, delivering a robustness that is rare in the industry. With a keen focus on human outcomes, it incorporates a translatability engine that efficiently translates insights between species. Importantly, the BIOiSIMTM platform is applicable before initiating preclinical animal trials, enabling earlier insights and significantly lowering costs linked to outsourced testing. This cutting-edge methodology not only improves efficiency but also hastens the overall drug development timeline, ultimately aiding the search for effective therapies. By streamlining the process, BIOiSIMTM has the potential to contribute to significant advancements in medicine.